We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRE icon
2351
Costamare
CMRE
$1.77B
$467K ﹤0.01%
77,014
+7,087
+10% +$40.9K
AXNX
2352
DELISTED
Axonics, Inc. Common Stock
AXNX
$464K ﹤0.01%
17,219
+98
+0.6% +$3.41K
CATC
2353
DELISTED
CAMBRIDGE BANCORP
CATC
$464K ﹤0.01%
6,183
+478
+8% +$36.9K
BVH
2354
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$464K ﹤0.01%
19,885
+1,738
+10% +$38.5K
RBB icon
2355
RBB Bancorp
RBB
$456M
$463K ﹤0.01%
23,529
+2,071
+10% +$39.6K
SAFE
2356
DELISTED
Safehold Inc.
SAFE
$462K ﹤0.01%
15,162
+3,420
+29% +$104K
LIND icon
2357
Lindblad Expeditions
LIND
$2.23B
$461K ﹤0.01%
27,499
-325
-1% -$5.91K
BXC icon
2358
BlueLinx
BXC
$570M
$460K ﹤0.01%
14,225
+1,206
+9% +$30.4K
GTES icon
2359
Gates Industrial Corporation Ltd.
GTES
$7.42B
$460K ﹤0.01%
45,726
-200
-0.4% -$1.96K
ALEC icon
2360
Alector
ALEC
$165M
$459K ﹤0.01%
31,829
+21,716
+215% +$392K
TRUE
2361
DELISTED
TrueCar
TRUE
$459K ﹤0.01%
134,982
-3,721
-3% -$16.5K
PDLI
2362
DELISTED
PDL BioPharma, Inc.
PDLI
$457K ﹤0.01%
211,696
+15,035
+8% +$40.2K
VSEC icon
2363
VSE Corp
VSEC
$6.05B
$455K ﹤0.01%
13,356
+1,059
+9% +$32.2K
KRO icon
2364
KRONOS Worldwide
KRO
$714M
$454K ﹤0.01%
36,737
+2,937
+9% +$36.4K
UTMD icon
2365
Utah Medical Products
UTMD
$227M
$454K ﹤0.01%
4,733
+68
+1% +$6.32K
TAST
2366
DELISTED
Carrols Restaurant Group, Inc.
TAST
$454K ﹤0.01%
54,777
+4,244
+8% +$35.5K
ATEX icon
2367
Anterix
ATEX
$1.94B
$452K ﹤0.01%
12,498
+590
+5% +$24.9K
CTMX icon
2368
CytomX Therapeutics
CTMX
$729M
$452K ﹤0.01%
61,208
+921
+2% +$9.09K
WLDN icon
2369
Willdan Group
WLDN
$1.16B
$452K ﹤0.01%
12,882
-40
-0.3% -$1.43K
GTT
2370
DELISTED
GTT Communications, Inc.
GTT
$452K ﹤0.01%
48,018
-350
-0.7% -$3.94K
FC icon
2371
Franklin Covey
FC
$247M
$451K ﹤0.01%
12,872
-75
-0.6% -$2.71K
FNLC icon
2372
First Bancorp
FNLC
$399M
$451K ﹤0.01%
16,421
+1,583
+11% +$41K
OPY icon
2373
Oppenheimer Holdings
OPY
$1.24B
$451K ﹤0.01%
15,016
+1,269
+9% +$36.5K
TWI icon
2374
Titan International
TWI
$471M
$451K ﹤0.01%
167,144
+10,829
+7% +$35.6K
LFCR icon
2375
Lifecore Biomedical
LFCR
$167M
$450K ﹤0.01%
41,403
+3,146
+8% +$34.2K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.